AWM
PLSE icon

Avior Wealth Management’s Pulse Biosciences PLSE Stock Holding History

Avior Wealth Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$26 – 3332
2024
Q1 		$26 Buy
+3
New +$28 ﹤0.01% 3642

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Avior Wealth Management's PLSE Position: Q2 2024 in Review

Avior Wealth Management sold out of Pulse Biosciences (PLSE) in Q2 2024, closing a stake of 3 shares — an estimated $26 sold.

Avior Wealth Management first reported a position in PLSE in Q1 2024 and held it in 1 quarter. The position peaked at $26 in Q1 2024. 57 funds tracked by Wall St. Rank hold PLSE as of Q2 2024.

  • Avior Wealth Management reported no remaining Pulse Biosciences position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 3 Pulse Biosciences shares in Q2 2024, an estimated $26.
  • Avior Wealth Management first reported a position in Pulse Biosciences in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's Pulse Biosciences position peaked at $26 in Q1 2024.
  • 57 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.